Partner Harold Wegner was quoted in a Reuters article published on June 3, 2014, titled “U.S. Supreme Court Rulings May Make Life Harder for Patent Trolls.” The article discussed the U.S. Supreme Court’s decision to vacate an appeals court decision in the case, Nautilus v. Biosig, which was being used to raise the bar on how much detail needs to be in a patent to avoid charges of being “indefinite.” According to Wegner, that ruling was the first since 1942 where the Supreme Court addressed the issue of how unclear, or “indefinite,” a patent could be before it would be deemed invalid.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”